PMA supplement
P120016 S024: VASCADE MVP Venous Vascular Closure System (VVCS)
FDA PMA supplement · Panel Track · Cardiva Medical, Inc.
Key facts
| Original PMA | P120016 |
|---|---|
| Supplement number | S024 |
| Supplement type | Panel Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | VASCADE MVP Venous Vascular Closure System (VVCS) |
| Generic name | Device, hemostasis, vascular |
| Applicant | Cardiva Medical, Inc. |
| Product code | MGB |
| Received date | May 30, 2018 |
| Decision date | Nov 27, 2018 |
| Docket number | 18M-4582 |
| Notice date | Dec 6, 2018 |
At a glance
- No Expedited review granted
- Yes Approval order on file
- Yes Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: